These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 24060925)
1. Effect of solvent type on retardation properties of diltiazem HCl form liquisolid tablets. Adibkia K; Shokri J; Barzegar-Jalali M; Solduzian M; Javadzadeh Y Colloids Surf B Biointerfaces; 2014 Jan; 113():10-4. PubMed ID: 24060925 [TBL] [Abstract][Full Text] [Related]
2. Effect of solvent on retarding the release of diltiazem HCl from Polyox-based liquisolid tablets. Kaialy W; Bello H; Asare-Addo K; Nokhodchi A J Pharm Pharmacol; 2016 Nov; 68(11):1396-1402. PubMed ID: 27714817 [TBL] [Abstract][Full Text] [Related]
3. Liquisolid technique as a new approach to sustain propranolol hydrochloride release from tablet matrices. Javadzadeh Y; Musaalrezaei L; Nokhodchi A Int J Pharm; 2008 Oct; 362(1-2):102-8. PubMed ID: 18647643 [TBL] [Abstract][Full Text] [Related]
4. Liquisolid compacts: the effect of cosolvent and HPMC on theophylline release. Nokhodchi A; Aliakbar R; Desai S; Javadzadeh Y Colloids Surf B Biointerfaces; 2010 Aug; 79(1):262-9. PubMed ID: 20451361 [TBL] [Abstract][Full Text] [Related]
5. An investigation of physicochemical properties of piroxicam liquisolid compacts. Javadzadeh Y; Siahi MR; Asnaashari S; Nokhodchi A Pharm Dev Technol; 2007; 12(3):337-43. PubMed ID: 17613897 [TBL] [Abstract][Full Text] [Related]
6. Liquisolid technique for dissolution rate enhancement of a high dose water-insoluble drug (carbamazepine). Javadzadeh Y; Jafari-Navimipour B; Nokhodchi A Int J Pharm; 2007 Aug; 341(1-2):26-34. PubMed ID: 17498898 [TBL] [Abstract][Full Text] [Related]
7. Preparation of sustained-release dosage form of Venlafaxine HCl using liquisolid technique. Khanfar M; Sheikh Salem M; Kaddour F Pharm Dev Technol; 2014 Feb; 19(1):103-15. PubMed ID: 23347382 [TBL] [Abstract][Full Text] [Related]
8. Liquisolid technique as a tool for enhancement of poorly water-soluble drugs and evaluation of their physicochemical properties. Javadzadeh Y; Siahi MR; Asnaashari S; Nokhodchi A Acta Pharm; 2007 Mar; 57(1):99-109. PubMed ID: 19839410 [TBL] [Abstract][Full Text] [Related]
9. Influence of formulation parameters on dissolution rate enhancement of glyburide using liquisolid technique. Singh SK; Srinivasan KK; Gowthamarajan K; Prakash D; Gaikwad NB; Singare DS Drug Dev Ind Pharm; 2012 Aug; 38(8):961-70. PubMed ID: 22251080 [TBL] [Abstract][Full Text] [Related]
10. The effect of type and concentration of vehicles on the dissolution rate of a poorly soluble drug (indomethacin) from liquisolid compacts. Nokhodchi A; Javadzadeh Y; Siahi-Shadbad MR; Barzegar-Jalali M J Pharm Pharm Sci; 2005 Jan; 8(1):18-25. PubMed ID: 15946594 [TBL] [Abstract][Full Text] [Related]
11. Effects of liquisolid formulations on dissolution of naproxen. Tiong N; Elkordy AA Eur J Pharm Biopharm; 2009 Nov; 73(3):373-84. PubMed ID: 19679184 [TBL] [Abstract][Full Text] [Related]
12. Formulation factors affecting the release of ezetimibe from different liquisolid compacts. Khanfar M; Sheikh Salem M; Hawari R Pharm Dev Technol; 2013; 18(2):417-27. PubMed ID: 22530561 [TBL] [Abstract][Full Text] [Related]
13. Enhancement of ketoconazole dissolution rate by the liquisolid technique. Molaei MA; Osouli-Bostanabad K; Adibkia K; Shokri J; Asnaashari S; Javadzadeh Y Acta Pharm; 2018 Sep; 68(3):325-336. PubMed ID: 31259692 [TBL] [Abstract][Full Text] [Related]
14. Mechanistic aspects of drug loading in liquisolid systems with hydrophilic lipid-based mixtures. Vraníková B; Niederquell A; Ditzinger F; Šklubalová Z; Kuentz M Int J Pharm; 2020 Mar; 578():119099. PubMed ID: 32006624 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of in vitro dissolution profile comparison methods of sustained release tramadol hydrochloride liquisolid compact formulations with marketed sustained release tablets. Karmarkar AB; Gonjari ID; Hosmani AH; Dhabale PN Drug Discov Ther; 2010 Feb; 4(1):26-32. PubMed ID: 22491149 [TBL] [Abstract][Full Text] [Related]
16. Formulation Development of Mirtazapine Liquisolid Compacts: Optimization Using Central Composite Design. Naureen F; Shah Y; Shah SI; Abbas M; Rehman IU; Muhammad S; Hamdullah H; Goh KW; Khuda F; Khan A; Chan SY; Mushtaq M; Ming LC Molecules; 2022 Jun; 27(13):. PubMed ID: 35807252 [TBL] [Abstract][Full Text] [Related]
17. [Liquisolid technique for enhancement of dissolution prosperities of tanshinone II(A)]. Liu XQ; Meng QJ; Xu XL; Zhao J; Yang H; Yi H Zhongguo Zhong Yao Za Zhi; 2015 Dec; 40(24):4840-6. PubMed ID: 27245032 [TBL] [Abstract][Full Text] [Related]
18. In vitro release evaluation of hydrocortisone liquisolid tablets. Spireas S; Sadu S; Grover R J Pharm Sci; 1998 Jul; 87(7):867-72. PubMed ID: 9649356 [TBL] [Abstract][Full Text] [Related]
19. Enhancement of dissolution rate of piroxicam using liquisolid compacts. Javadzadeh Y; Siahi-Shadbad MR; Barzegar-Jalali M; Nokhodchi A Farmaco; 2005 Apr; 60(4):361-5. PubMed ID: 15848213 [TBL] [Abstract][Full Text] [Related]
20. Liquisolid technique to enhance and to sustain griseofulvin dissolution: effect of choice of non-volatile liquid vehicles. Elkordy AA; Essa EA; Dhuppad S; Jammigumpula P Int J Pharm; 2012 Sep; 434(1-2):122-32. PubMed ID: 22677418 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]